全文获取类型
收费全文 | 7709篇 |
免费 | 423篇 |
国内免费 | 61篇 |
专业分类
耳鼻咽喉 | 146篇 |
儿科学 | 231篇 |
妇产科学 | 89篇 |
基础医学 | 911篇 |
口腔科学 | 155篇 |
临床医学 | 453篇 |
内科学 | 2160篇 |
皮肤病学 | 92篇 |
神经病学 | 486篇 |
特种医学 | 441篇 |
外科学 | 1402篇 |
综合类 | 34篇 |
一般理论 | 1篇 |
预防医学 | 149篇 |
眼科学 | 125篇 |
药学 | 373篇 |
中国医学 | 13篇 |
肿瘤学 | 932篇 |
出版年
2023年 | 69篇 |
2022年 | 170篇 |
2021年 | 267篇 |
2020年 | 114篇 |
2019年 | 185篇 |
2018年 | 222篇 |
2017年 | 189篇 |
2016年 | 202篇 |
2015年 | 201篇 |
2014年 | 263篇 |
2013年 | 340篇 |
2012年 | 545篇 |
2011年 | 566篇 |
2010年 | 299篇 |
2009年 | 229篇 |
2008年 | 430篇 |
2007年 | 472篇 |
2006年 | 464篇 |
2005年 | 506篇 |
2004年 | 417篇 |
2003年 | 465篇 |
2002年 | 442篇 |
2001年 | 72篇 |
2000年 | 66篇 |
1999年 | 96篇 |
1998年 | 100篇 |
1997年 | 71篇 |
1996年 | 76篇 |
1995年 | 77篇 |
1994年 | 57篇 |
1993年 | 66篇 |
1992年 | 46篇 |
1991年 | 35篇 |
1990年 | 27篇 |
1989年 | 35篇 |
1988年 | 28篇 |
1987年 | 19篇 |
1986年 | 28篇 |
1985年 | 26篇 |
1984年 | 24篇 |
1983年 | 22篇 |
1982年 | 10篇 |
1981年 | 22篇 |
1980年 | 17篇 |
1979年 | 25篇 |
1978年 | 8篇 |
1977年 | 7篇 |
1976年 | 9篇 |
1975年 | 9篇 |
1971年 | 7篇 |
排序方式: 共有8193条查询结果,搜索用时 8 毫秒
941.
942.
The incidence and risk factors of cholesterol embolization syndrome,a complication of cardiac catheterization: a prospective study 总被引:4,自引:0,他引:4
Fukumoto Y Tsutsui H Tsuchihashi M Masumoto A Takeshita A;Cholesterol Embolism Study 《Journal of the American College of Cardiology》2003,42(2):211-216
BACKGROUND: Cholesterol embolization syndrome is a systemic disease caused by distal showering of cholesterol crystals after angiography, major vessel surgery, or thrombolysis. METHODS: We prospectively evaluated a total of 1,786 consecutive patients 40 years of age and older, who underwent left-heart catheterization at 11 participating hospitals. The diagnosis of CES was made when patients had peripheral cutaneous involvement (livedo reticularis, blue toe syndrome, and digital gangrene) or renal dysfunction. RESULTS: Twenty-five patients (1.4%) were diagnosed as having CES. Twelve patients (48%) had cutaneous signs, and 16 patients (64%) had renal insufficiency. Eosinophil counts were significantly higher in CES patients than in non-CES patients before and after cardiac catheterization. The in-hospital mortality rate was 16.0% (4 patients), which was significantly higher than that without CES (0.5%, p < 0.01). All four patients with CES who died after cardiac catheterization had progressive renal dysfunction. The incidence of CES increased in patients with atherosclerotic disease, hypertension, a history of smoking, and the elevation of baseline plasma C-reactive protein (CRP) by univariate analysis. The femoral approach did not increase the incidence, suggesting a possibility that the ascending aorta may be a potential embolic source. As an independent predictor of CES, multivariate regression analysis identified only the elevation of pre-procedural CRP levels (odds ratio 4.6, P = 0.01). CONCLUSIONS: Cholesterol embolization syndrome is a relatively rare but serious complication after cardiac catheterization. Elevated plasma levels of pre-procedural CRP are associated with subsequent CES in patients who undergo vascular procedures. 相似文献
943.
Masaru Enomoto Akihiro Tamori Madoka Toyama Kohmoto Takehiro Hayashi Hiroyasu Morikawa Hisato Jomura Hiroki Sakaguchi Daiki Habu Norifumi Kawada Susumu Shiomi Shuhei Nishiguchi 《Hepatology research》2008,38(9):954-959
Aim: The endpoint of treatment with nucleoside analogs remains unclear for patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B. We report the results of a randomized trial to determine the optimal duration of additional therapy after response to lamivudine in HBeAg-negative patients.
Methods: Twenty-two patients with HBeAg-negative chronic hepatitis B who exhibited biochemical and virological responses to lamivudine were enrolled. When patients responded to treatment, they were randomly assigned to receive 12 more months of therapy (Group A, 11 patients) or 24 more months of therapy (Group B, 11 patients).
Results: The baseline characteristics of the patients were similar in the two groups. Biochemical and virological responses were obtained in all patients within 6 months. Drug resistance developed in one patient in Group A during month 7 of additional therapy, and in five patients in Group B from months 13–23 of additional therapy. Ten patients in Group A and six in Group B completed the protocol and were included in analysis. Eight of the 10 patients in Group A experienced relapse between months 2 and 14 after the discontinuation of therapy, while three of the six patients in Group B experienced relapse between months 2 and 24. There was no difference in cumulative relapse rate between the groups ( P = 0.275).
Conclusion: Additional therapy with lamivudine for longer than 12 months after biochemical and virological responses in patients with HBeAg-negative chronic hepatitis B could increase the risk of drug resistance, but did not reduce the rate of relapse. 相似文献
Methods: Twenty-two patients with HBeAg-negative chronic hepatitis B who exhibited biochemical and virological responses to lamivudine were enrolled. When patients responded to treatment, they were randomly assigned to receive 12 more months of therapy (Group A, 11 patients) or 24 more months of therapy (Group B, 11 patients).
Results: The baseline characteristics of the patients were similar in the two groups. Biochemical and virological responses were obtained in all patients within 6 months. Drug resistance developed in one patient in Group A during month 7 of additional therapy, and in five patients in Group B from months 13–23 of additional therapy. Ten patients in Group A and six in Group B completed the protocol and were included in analysis. Eight of the 10 patients in Group A experienced relapse between months 2 and 14 after the discontinuation of therapy, while three of the six patients in Group B experienced relapse between months 2 and 24. There was no difference in cumulative relapse rate between the groups ( P = 0.275).
Conclusion: Additional therapy with lamivudine for longer than 12 months after biochemical and virological responses in patients with HBeAg-negative chronic hepatitis B could increase the risk of drug resistance, but did not reduce the rate of relapse. 相似文献
944.
Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling. 总被引:1,自引:0,他引:1
Fumitoshi Satoh Takaaki Abe Masayuki Tanemoto Masahiro Nakamura Michiaki Abe Akira Uruno Ryo Morimoto Akihiro Sato Kei Takase Shigeto Ishidoya Yoichi Arai Takashi Suzuki Hironobu Sasano Tadashi Ishibashi Sadayoshi Ito 《Hypertension research》2007,30(11):1083-1095
Accurate localization of aldosterone-producing adenoma (APA) is essential for the treatment of primary aldosteronism (PA). In order to confirm the clinical usefulness of adrenal venous sampling (AVS), we retrospectively studied 87 cases of PA in whom AVS was conducted. We collected right and left adrenal venous effluents simultaneously before and after adrenocorticotropic hormone (ACTH) stimulation for measurements of aldosterone concentration (A) and cortisol concentration (C). Based on AVS results, we judged 66 cases as having unilateral aldosterone hypersecretion and the remaining 21 cases as having no apparent laterality. Of the above 66 subjects, 61 underwent laparoscopic removal of the adrenal gland through a retroperitoneal approach. The presence of APA was histopathologically confirmed, and blood pressure decreased significantly with normalization of plasma aldosterone concentration (PAC) in all cases. The receiver operator characteristics (ROC) curve analysis between the operated and no-apparent-laterality groups revealed that the ratio of A/C on the higher side to A/C on the lower side (A/C ratio) after ACTH stimulation is a useful index, with a cutoff value of 2.6, a sensitivity of 0.98 and a specificity of 1.0. The ROC curve analysis between the APA side and contralateral side within the operated patients revealed that the cutoff value of A was 1,340 ng/dL, with a sensitivity of 0.92 and a specificity of 1.00. Our results indicate the usefulness of simultaneous AVS and ACTH stimulation for localizing APA. 相似文献
945.
OBJECTIVE: To estimate the prevalence and risk of ischemic stroke associated with metabolic syndrome. METHODS AND PATIENTS: In 197 stroke patients (80 cases of atherothrombotic infarction, 97 lacunar infarction, 16 cardioembolic infarction, 4 others) and 356 age- and sex-matched control subjects aged 65 years and older in Seiyo Municipal Nomura Hospital, we investigated the association between metabolic syndrome and risk factor-dependent augmentation of ischemic stroke in subjects with several risk factors for atherosclerosis. The diagnosis of cerebral infarction in each patient was confirmed by CT findings of the brain and metabolic syndrome was defined as at least 3 of the 5 following conditions: visceral obesity, hypertension (HT), hypertriglyceridemia, low HDL-cholesterol and diabetes mellitus (DM). RESULTS: After adjustment for sex, age, and smoking, metabolic syndrome was significantly related to atherothrombotic infarction (odds ratio, 3.08; 95% confidence interval, 1.69-5.61). Of the individual components, visceral obesity, HT and DM were independent risk factors for atherothrombotic infarction. Increased risk for atherothrombotic infarction was also associated with increases in the 5 component conditions of the metabolic syndrome. CONCLUSION: The clustering of cardiovascular risk factors called metabolic syndrome increases the risk of cardiovascular morbidity, and its identification may thus be important in risk assessment and treatment of patients. 相似文献
946.
Hiromi Saitoh MD Keiichi Takagaki MD Toshiya Nakamura MD Akihiro Munakata MD Yutaka Yoshida MD Dr. Masahiko Endo MD 《Digestive diseases and sciences》1996,41(9):1768-1774
Whole-gut lavage fluid, collected by administering an electrolyte lavage solution orally, was found to be an excellent and easily collectable source of abundant mucin. Furthermore, the biochemical features of the mucin from patients with ulcerative colitis and Crohn's disease were investigated. The mucin was separated into four fractions by Sepharose CL-4B, Sepharose CL-2B, and DEAE Sephacel chromatography. Compared with healthy subjects, the total yields of mucin from ulcerative colitis patients were low due to a deficiency of neutral mucin, whereas those from Crohn's disease patients were high, which was attributable mainly to high-molecular-weight mucin. The fucose and sulfate contents were low in ulcerative colitis, but only the former was low in Crohn's disease. The different biochemical features of the mucin obtained from whole gut lavage fluid appear to reflect mucosal pathological changes associated with inflammatory bowel disease. 相似文献
947.
Chisato Tomoda Hiroya Kitano Takashi Uruno Yuuki Takamura Yasuhiro Ito Akihiro Miya Kaoru Kobayashi Fumio Matsuzuka Nobuyuki Amino Kanji Kuma Akira Miyauchi 《Thyroid》2005,15(6):600-603
Povidone-iodine is used as disinfection in patients undergoing many kinds of operations. Several cases of thyroid dysfunction induced by transcutaneous absorption of povidone-iodine have been reported in small infants. However, transcutaneous absorption was not clearly reported in adults. The aim of this study was to assess transcutaneous absorption of iodine in patients who received single topical application with povidoneiodine and serial changes of urinary iodine excretion under the condition with a simple iodine-restricted diet in Japan, an iodine-sufficient area. Sixty-eight patients with thyroid carcinoma undergoing total thyroidectomy received single skin disinfection with either povidone-iodine (group A; n = 47) or chlohexidine gluconate, a noniodine containing biguanide (group B; n = 21). In group A, urinary iodine excretion on the first day after operation increased up to 7 times that of the preoperative value. The amounts of urinary iodine correlated positively with operating time. Increased urinary iodine, however, returned to preoperative values on the third or fifth day after operation. In group B, there was no increase in urinary iodine excretion and urinary iodine excretion was ranged from 54 to 193 microg/g of creatinine on the third day of operation. In conclusion, a large amount of povidone-iodine was absorbed through healthy skin even in adults. This may possibly interfere with scintigraphy or radioactive iodine treatment, or cause thyroid disinfection in susceptible patients. 相似文献
948.
Shigeru Nakai Ikuto Masakane Takashi Akiba Takashi Shigematsu Kunihiro Yamagata Yuzo Watanabe Kunitoshi Iseki Noritomo Itami Toshio Shinoda Kunio Morozumi Tetsuo Shoji Seiji Marubayashi Osamu Morita Naoki Kimata Tatsuya Shoji Kazuyuki Suzuki Kenji Tsuchida Hidetomo Nakamoto Takayuki Hamano Akihiro Yamashita Kenji Wakai Atsushi Wada Yoshiharu Tsubakihara 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2008,12(6):428-456
A statistical survey of dialysis patients for the year 2006 was carried out for 4051 medical facilities across Japan, and responses were received from 3985 (98.37%) facilities. There were 264 473 dialysis patients (including 9003 peritoneal dialysis patients) in Japan at the end of 2006, which showed an increase of 6708 (2.6%) from the end of 2005. The number of patients per million population was 2069.9. The crude mortality rate during 2006 was 9.2%. The mean age of the patients who began dialysis (in 2006) was 66.4 years, and the mean age of the entire dialysis population was 64.4 years. The primary renal diseases of the patients who began dialysis were diabetic nephropathy (42.9%), chronic glomerulonephritis (25.6%), and nephrosclerosis (9.4%). Of the 3488 facilities that participated in the survey on the dialysate water quality, 2873 facilities (82.4%) measured the endotoxin concentration in the dialysate; and 1197 facilities (37.1%) out of 3228 measured the bacterial count in the dialysate. The mean hemoglobin concentration in the dialysis population at the end of 2006 was 10.23 ± 1.33 g/dL, which was equal to that at the end of 2005 (10.23 ± 1.37 g/dL). The mean concentration of serum creatinine in 15 853 patients who started dialysis during 2006 was 8.37 ± 3.58 mg/dL. The estimated glomerular filtration rate, which was calculated with formula modified for the Japanese population from the Modification of Diet in Renal Disease (MDRD) Study equation, was 5.46 ± 6.60 mL/min/1.73 m2. 相似文献
949.
Yosuke Murase Yoshiji Yamada Akihiro Hirashiki Sahoko Ichihara Hirofumi Kanda Masato Watarai Fumimaro Takatsu Toyoaki Murohara Mitsuhiro Yokota 《European heart journal》2004,25(11):970-977
AIMS: The aim of the study was to identify genes that confer susceptibility to coronary artery spasm and clarify the interaction between genetic and environmental factors in this condition. METHODS AND RESULTS: The study population comprised 2188 Japanese individuals, including 593 subjects with coronary artery spasm (453 men, 140 women) and 1595 controls (762 men, 833 women). The genotypes for 35 polymorphisms of 29 candidate genes were determined with an allele-specific DNA primer-probe assay. Multivariable logistic regression analysis adjusted for age, body mass index, and the prevalence of smoking, hypertension, diabetes mellitus, hypercholesterolaemia, and hyperuricaemia revealed a significant association with coronary artery spasm of one polymorphism (242C-->T in the NADH/NADPH oxidase p22 phox gene) in men and two polymorphisms (-1171/5A-->6A in the stromelysin-1 gene and -634C-->G in the interleukin-6 gene) in women. A stepwise forward selection procedure revealed that smoking was the most important risk factor for coronary artery spasm and that the effects of these polymorphisms on this condition were statistically independent of smoking. CONCLUSION: The NADH/NADPH oxidase p22 phox gene is a susceptibility locus for coronary artery spasm in men, and the stromelysin-1 and interleukin-6 genes are susceptibility loci in women. 相似文献
950.
Akihiro Funakoshi Yohichi Yasunami Shinichiroh Ryu Hirotsugu Shinozaki Atsuo Jimi 《Journal of gastroenterology》1994,29(6):797-799
Human glucagonoma cells were isolated and maintained in vitro. Incubation experiments showed that carbachol (Cch) induced the simultaneous release of glucagon, VIP (vasoactive intestinal polypeptide), and pancreatic polypeptide (PP) at levels significantly higher than basal levels. Atropine abolished the stimulatory effect of Cch on glucagon, VIP, and PP release. An immunohistological study of the tumor tissues revealed that the cells contained glucagon, VIP, and PP. These findings demonstrate, for the first time, the in vitro release of glucagon from glucagonoma cells by Cch stimulation. 相似文献